ArticleAnnals of rehabilitation medicine2026
Enhancing Diagnostic Precision and Treatment Effectiveness Using Indocyanine Green Lymphography in Lymphedema.
Article in Annals of rehabilitation medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Indocyanine green (ICG) lymphography has rapidly emerged as a key imaging modality for improving the diagnosis and management of lymphedema. ICG lymphography offers superior sensitivity and detailed assessment of dermal backflow patterns, functional lymphatic channels, and collateral drainage routes. Evidence also supports its role in guiding targeted rehabilitation, including ICG-guided lymphedema treatment. Clinicians can enhance diagnostic precision and potentially improve therapeutic effectiveness by integrating ICG lymphography into clinical practice. This review summarizes current evidence on its clinical utility, highlighting how real-time visualization of superficial lymphatic pathways and lymph nodes allows for detection of dysfunction, and improved treatment planning. Future work should focus on standardizing protocols and developing quantitative metrics to expand its values in comprehensive lymphedema care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.